Organon & Co. Common Stock

Afficher le graphique complet Full chart

Financials

Total de l'actif 10.68 B10.96 B12.06 B13.1 B12.87 B Total du passif 12.45 B12.04 B12.13 B12.63 B12.12 B Total des capitaux propres -1.51 B-892 M-70 M472 M752 M Total du passif et des capitaux propres 10.68 B10.96 B12.06 B13.1 B12.87 B Dette totale 9.13 B8.9 B8.75 B8.86 B8.64 B Dette nette 9.13 B8.9 B8.75 B8.86 B8.07 B

Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

OGN

Financials

Organon & Co. Common Stock

Nouvelles

Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know

L’action Organon & Co atteint un sommet annuel à 13,44$

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

L’action Organon & Co atteint un plus haut sur 52 semaines à 13,4 USD

Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It

An April To Remember For Stocks

Organon (OGN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Organon (OGN) Q1 Earnings and Revenues Miss Estimates

Organon déçoit les attentes avec un chiffre d’affaires en baisse de 9%

Company News for Apr 28, 2026

Nasdaq Futures Slip as AI Concerns Resurface, FOMC Meeting and Earnings in Focus

Tech Earnings Optimism Powers Stocks Higher